extended release
Showing 1 - 25 of 8,355
Cannabis Use Disorder Trial in Parkville (Guanfacine Extended Release Oral Tablet, Residential withdrawal, Engagement with
Not yet recruiting
- Cannabis Use Disorder
- Guanfacine Extended Release Oral Tablet
- +3 more
-
Parkville, Victoria, AustraliaOrygen
Jul 16, 2023
Atopic Dermatitis Trial in Hangzhou (TLL-018 extended-release tablet, TLL-018 immediate-release tablet)
Active, not recruiting
- Atopic Dermatitis
- TLL-018 extended-release tablet
- TLL-018 immediate-release tablet
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital Zhejiang University School of Med
Jul 12, 2023
Narcolepsy Type 1, Narcolepsy With Cataplexy Trial (NLS-2, Placebo)
Not yet recruiting
- Narcolepsy Type 1
- Narcolepsy With Cataplexy
- NLS-2
- Placebo
- (no location specified)
Jun 21, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza Garcia, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
End Stage Renal Disease, Rejection of Renal Transplant Trial in Chicago (Tacrolimus, Tacrolimus Extended Release Oral Tablet
Completed
- End Stage Renal Disease
- Rejection of Renal Transplant
- Tacrolimus
- Tacrolimus Extended Release Oral Tablet [Envarsus]
-
Chicago, IllinoisNorthwestern University
Jan 12, 2023
Cocaine Use Disorder Trial (Extended-Release Naltrexone, Extended Release Buprenorphine, Placebo (PLB) Injectable)
Not yet recruiting
- Cocaine Use Disorder
- Extended-Release Naltrexone
- +2 more
- (no location specified)
Jul 15, 2022
Somatic Symptom Trial in Shanghai (toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Somatic Symptom
- toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
May 6, 2023
Advanced Cancer Trial in Taichung, Tainan (CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule))
Completed
- Advanced Cancer
- CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule)
-
Taichung, Taiwan
- +1 more
Nov 25, 2022
Opioid Use Disorder Trial (Buprenorphine Extended-Release Injection)
Not yet recruiting
- Opioid Use Disorder
- Buprenorphine Extended-Release Injection
- (no location specified)
Feb 2, 2023
Opioid Use Disorder Trial in New York (Extended-Release Buprenorphine (XRB), Sublingual Buprenorphine (SLB))
Not yet recruiting
- Opioid Use Disorder
- Extended-Release Buprenorphine (XRB)
- Sublingual Buprenorphine (SLB)
-
New York, New YorkNYU Langone Health - 180 Madison Ave
Sep 18, 2023
Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)
Not yet recruiting
- Epilepsy
- Lacosamide Tablets
- Lacosamide extended release tablets
-
Wuhan, Hubei, ChinaUnion Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023
Healthy Trial in Lenexa, Salt Lake City, Groningen (RPV LA, CAB LA)
Recruiting
- Healthy
- RPV LA
- CAB LA
-
Lenexa, Kansas
- +2 more
Jan 17, 2023
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
Lung Carcinoma Trial in Aurora, Buffalo, Vancouver (Extended Release Metformin Hydrochloride)
Recruiting
- Lung Carcinoma
- Biopsy
- +4 more
-
Aurora, Colorado
- +2 more
Jan 28, 2023
Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release
Recruiting
- Migraine Prophylaxis
- Nicotinic Acid 500 MG Extended Release Oral Tablet
- +2 more
-
Dhaka, BangladeshBSMMU
May 5, 2023
MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)
Recruiting
- Major Depressive Disorder
- Toludivenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jun 14, 2023
Opioid-use Disorder Trial in New York (extended-release buprenorphine (BXR), sublingual buprenorphine (BSL))
Recruiting
- Opioid-use Disorder
- extended-release buprenorphine (BXR)
- sublingual buprenorphine (BSL)
-
New York, New YorkNyspi-Stars
Sep 29, 2022
Rotator Cuff Tears, Rotator Cuff Tendinitis, Rotator Cuff Impingement Trial in Great Neck (FX006 Injection)
Recruiting
- Rotator Cuff Tears
- +4 more
- FX006 Injection
-
Great Neck, New YorkNorthwell Health Orthopedic Institute at Great Neck
Dec 27, 2022
Kidney Transplantation, Pancreas Transplantation, Diabetes Trial in Nantes (Tacrolimus and Tacrolimus Extended Release Oral
Recruiting
- Kidney Transplantation
- +2 more
- Tacrolimus and Tacrolimus Extended Release Oral Tablet [Envarsus]
-
Nantes, FranceNantes University Hospital
Aug 10, 2022
Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))
Not yet recruiting
- Healthy
- TR-01-XRR (1)
- +6 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Feb 3, 2023
Healthy Trial in Nottingham (BLU-5937 IR, BLU-5937 ER)
Recruiting
- Healthy
- BLU-5937 IR
- BLU-5937 ER
-
Nottingham, England, United KingdomQuotient Sciences
Oct 4, 2022
Anesthesiology, Orthopedic Trial in Taipei city (DS group, Control group)
Recruiting
- Anesthesiology
- Orthopedic
- DS group
- Control group
-
Taipei city, TaiwanTri-Service General Hospital
Oct 20, 2022